Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Omeprazole

SKU: orb1310319

Description

Omeprazole

Research Area

Cell Biology, Infectious Disease & Virology, Metabolism Research, Pharmacology & Drug Discovery

Images & Validation

Key Properties

CAS Number73590-58-6
MW345.4
Purity>98%
FormulaC17H19N3O3S
SMILESS(CC1=C(C)C(OC)=C(C)C=N1)(=O)C=2NC=3C(N2)=CC=C(OC)C3
TargetATPase
SolubilitySoluble in DMSO (up to 30 mg/ml) or in Ethanol (up to 5 mg/ml)

Bioactivity

In Vivo
Omeprazole diminishes the activation of osteoclasts in vitro, while enhancing the activation of osteoblasts, leading to osteosclerosis-like effects to some extent. In human hepatocellular carcinoma cells, omeprazole induces the transcription of reporter genes through dioxin receptor elements recognized by ligand-activated aryl hydrocarbon receptors. It effectively induces the expression of cytochrome P4501A1 mRNA in primary human hepatocytes, but this induction is not detected in mouse primary hepatocytes. Omeprazole significantly suppresses the basal natural killer (NK) activity in splenocytes (SC) from untreated CD2F1 mice. It exerts rapid and robust effects on various types of cytotoxic lymphocytes, ranging from the inhibition of cytotoxicity to irreversible cellular damage. Furthermore, omeprazole notably inhibits the cytotoxicity of all types of effector cells after 30 minutes of incubation.
In Vitro
Omeprazole transiently alters the kinetic properties of parietal cells in rabbits, leading to premature cell death and expedited growth. By inhibiting H(+)-K(+)-ATPase, omeprazole enhances the clearance of degenerative changes and macrophage-mediated removal of parietal cells, as well as promoting the increase of progenitor cells at the apical ridge.

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

H 16868, H16868, H-16868, Inhibitor, Losec, inhibit, Omeprazole, Bacterial, Autophagy, Antra, Proton Pump, Proton pump, Protonpump, Phospholipase, Prilosec

Similar Products

  • Omeprazole Impurity F and G mixture [orb1090009]

    ≥98%

    125656-82-8, 125656-83-9

    311.4

    1 mg, 5 mg, 25 mg
  • Omeprazole Related Compound B [orb610386]

    ≥99%

    37052-78-1

    180.23

    1 g, 5 g, 25 g
  • Omeprazole impurity 13 [orb3181543]

    220757-74-4

    333.83

    C16H16ClN3OS

    50 mg, 10 mg
  • Omeprazole Sodium [orb1305954]

    99.57% (May vary between batches)

    95510-70-6

    367.4

    C17H18N3NaO3S

    100 mg, 200 mg, 500 mg, 1 ml x 10 mM (in DMSO)
  • Esomeprazole [orb1306590]

    98.20% (May vary between batches)

    119141-88-7

    345.42

    C17H19N3O3S

    100 mg, 500 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Protocol Information

Available Sizes

Select a size below

50 mg
$ 160.00
500 mg
$ 240.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry